Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? - PubMed (original) (raw)

. 2009 Mar 10;100(5):795-8.

doi: 10.1038/sj.bjc.6604908. Epub 2009 Feb 3.

Collaborators, Affiliations

• PMID: 19190630
• PMCID: PMC2653775
• DOI: 10.1038/sj.bjc.6604908

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

R E Neale et al. Br J Cancer. 2009.

Erratum in

• Br J Cancer. 2009 May 5;100(9):1514. Sadhegi, S [corrected to Sadeghi, S]

Abstract

Since hyperinsulinaemia may promote obesity-linked cancers, we compared type 2 diabetes prevalence among oesophageal adenocarcinoma (OAC) patients and population controls. Diabetes increased the risk of OAC (adjusted odds ratio 1.59, 95% confidence interval (CI) 1.04-2.43), although the risk was attenuated after further adjusting for body mass index (1.32, 95% CI 0.85-2.05).

PubMed Disclaimer

Similar articles

• Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
  Pandeya N, Webb PM, Sadeghi S, Green AC, Whiteman DC; Australian Cancer Study. Pandeya N, et al. Gut. 2010 Jan;59(1):31-8. doi: 10.1136/gut.2009.190827. Gut. 2010. PMID: 19875392
• Motor vehicle exposure and risk of oesophageal adenocarcinoma.
  Lagergren J, Jansson C, Lu Y. Lagergren J, et al. Eur J Cancer. 2011 Jul;47(10):1446-9. doi: 10.1016/j.ejca.2011.04.017. Epub 2011 May 12. Eur J Cancer. 2011. PMID: 21570825
• Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
  Ljung R, Martin L, Lagergren J. Ljung R, et al. Eur J Cancer. 2011 Sep;47(14):2128-32. doi: 10.1016/j.ejca.2011.03.012. Epub 2011 Apr 12. Eur J Cancer. 2011. PMID: 21489778
• Epidemiology of esophageal cancer.
  Wheeler JB, Reed CE. Wheeler JB, et al. Surg Clin North Am. 2012 Oct;92(5):1077-87. doi: 10.1016/j.suc.2012.07.008. Epub 2012 Aug 20. Surg Clin North Am. 2012. PMID: 23026270 Review.
• Recent changes in the epidemiology of esophageal cancer.
  Pera M, Pera M. Pera M, et al. Surg Oncol. 2001 Nov;10(3):81-90. doi: 10.1016/s0960-7404(01)00025-1. Surg Oncol. 2001. PMID: 11750227 Review. No abstract available.

Cited by

• A case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer Study.
  Lahmann PH, Ibiebele TI, Webb PM, Nagle CM, Whiteman DC; Australian Cancer Study. Lahmann PH, et al. BMC Cancer. 2014 Nov 24;14:877. doi: 10.1186/1471-2407-14-877. BMC Cancer. 2014. PMID: 25421419 Free PMC article.
• CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.
  Starup-Linde J, Karlstad O, Eriksen SA, Vestergaard P, Bronsveld HK, de Vries F, Andersen M, Auvinen A, Haukka J, Hjellvik V, Bazelier MT, Boer Ad, Furu K, De Bruin ML. Starup-Linde J, et al. Curr Drug Saf. 2013 Nov;8(5):296-332. doi: 10.2174/15748863113086660071. Curr Drug Saf. 2013. PMID: 24215312 Free PMC article. Review.
• Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis.
  Xu B, Zhou X, Li X, Liu C, Yang C. Xu B, et al. Medicine (Baltimore). 2017 Sep;96(35):e7944. doi: 10.1097/MD.0000000000007944. Medicine (Baltimore). 2017. PMID: 28858123 Free PMC article. Review.
• Statin use is associated with a reduced incidence of colorectal adenomatous polyps.
  Broughton T, Sington J, Beales IL. Broughton T, et al. Int J Colorectal Dis. 2013 Apr;28(4):469-76. doi: 10.1007/s00384-012-1601-9. Epub 2012 Nov 1. Int J Colorectal Dis. 2013. PMID: 23114474
• Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.
  Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB. Petrick JL, et al. Cancer. 2019 Dec 1;125(23):4210-4223. doi: 10.1002/cncr.32444. Epub 2019 Sep 6. Cancer. 2019. PMID: 31490550 Free PMC article.

References

1. 1. Blot WJ, Devesa SS, Kneller RW, Fraumeni Jr JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287–1289 - PubMed
2. 1. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579–591 - PubMed
3. 1. Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, Ahmed A, Day NE (2000) A case–control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83: 127–132 - PMC - PubMed
4. 1. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni Jr JF (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90: 150–155 - PubMed
5. 1. Corley DA, Kubo A, Zhao W (2008) Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 17: 352–358 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Medical

  • MedlinePlus Health Information